Cancer Commons founder Marty Tenenbaum, Ph.D., will speak at the upcoming Precision Medicine World Conference (PMWC) in Durham, NC, which runs May 24–25. Marty, who founded Cancer Commons after his own battle with melanoma, will discuss the organization’s ongoing efforts to address challenges to knowledge-sharing in precision oncology. Read the synopsis of Marty’s presentation, entitled “Is An Additional Path to FDA Approval Possible?”: This talk will… Read more »
Oncologist and Cancer Commons Medical Director Kevin Knopf, MD, will speak next month at TiEcon 2017, a technology conference in Santa Clara, CA. He’ll join three other experts to discuss the future of personalized medicine. From the program: A new era of personalized medicine has made its way into the world of healthcare. We will discuss novel approaches for designing disease treatment and prevention that… Read more »
Ask MIT Neuroscientist Dr. Nancy Kanwisher what the most fascinating discovery about the human brain is in her eyes; she’ll tell you there’s a part of our brain that is selectively turned on only when we’re thinking about what other people are thinking about us. Though it was Dr. Kanwisher’s student and now colleague who made this discovery, she considers it the “coolest” of… Read more »
Connor (far left) with his family on a backpacking trip through the Lamar Valley in Yellowstone National Park
Volunteers are essential members of the Cancer Commons community. We are deeply grateful to those who have generously donated their time to helping us change the way the world treats cancer. This month, we celebrate the contributions of Cancer Commons volunteer Connor Sweetnam, who uses his engineering background to extract insights from our interactions with patients so they can be leveraged to help other… Read more »
Update 3-1-17: A video of this event has now been released. Watch it below. This year’s Precision Medicine World Conference in Mountain View, California, was well-attended by many members of Cancer Commons, who shared in the scientific discoveries that will lead the way to more personalized, accurate, and effective cancer care. Precision medicine is a rapidly evolving field with many breakthroughs in science, technology,… Read more »
One of Cancer Commons’ earliest and most generous supporters, Brit d’Arbeloff, is a woman of many talents who is dedicated to excellence in education. She is the first woman to earn an undergraduate mechanical engineering degree at Stanford University. In addition, she was the owner of a fashion boutique in Boston for over a decade. She also earned a graduate degree at MIT, where… Read more »
Everyone at Cancer Commons is very thankful for the outpouring of support that we received in 2016. As a nonprofit organization, we rely entirely on donations to provide cancer treatment decision support at no charge. These contributions have allowed Cancer Commons to respond to over 1,500 requests for help and will allow us to develop innovative technology to help many others in the months… Read more »
FOR IMMEDIATE RELEASE: Los Altos, California – January 25, 2017 – Cancer Commons, a nonprofit network of physicians, scientists and patients dedicated to helping each patient achieve the best possible outcome, announces the launch of a new program to identify personalized treatment options for children with brain cancer. The program is funded by a generous lead gift from Sheri Sobrato Brisson, a pediatric brain… Read more »
This month, every donation we receive will be matched by a few generous, anonymous donors. Help the next patient receive the options that they need by joining the Cancer Commons family of donors. Your philanthropic support allows us to provide treatment options at no charge. It also allows us to develop an online community knowledge base that will transform cancer care. By learning from every… Read more »
Cancer Commons Connects is our monthly newsletter featuring the latest insights and new developments at Cancer Commons. This month, we feature a new Super Patients post, a new post by our chief scientist Emma Shtivelman on two competing lung cancer drugs, and an interview with our medical director, Kevin Knopf. Click here to view the latest installment of Cancer Commons Connects. If you would like… Read more »
